As of 2:48pm ET
| -0.01 / -0.40%|
The 1 analysts offering 12-month price forecasts for CTi Biopharma Corp have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +180.00% increase from the last price of 2.50.
The current consensus among 1 polled investment analysts is to Buy stock in CTi Biopharma Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.